Bristol-Myers Squibb (BMY)
NYSE:BMY

Bristol-Myers Squibb (BMY) Ownership - Who Owns Bristol-Myers Squibb?

10,562 Followers

Bristol-Myers Squibb (BMY) Ownership Overview

0.34%24.79%26.25%48.62%
26.25% Other Institutional Investors
48.62% Public Companies and Individual Investors
The ownership structure of Bristol-Myers Squibb (BMY) stock is a mix of institutional, retail and individual investors. Approximately 51.04% of the company’s stock is owned by Institutional Investors, 0.34% is owned by Insiders and 48.62% is owned by Public Companies and Individual Investors.
The ownership structure of Bristol-Myers Squibb (BMY) stock is a mix of institutional, retail and individual investors. Approximately 51.04% of the company’s stock is owned by Institutional Investors, 0.34% is owned by Insiders and 48.62% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Dec 07, 2023
xxxxxxxxxxxxx
$99560
Nov 30, 2023
xxxxxxxxxxxxx
$150049
Nov 21, 2023
xxxxxxxxxxxxx
$423385
Aug 28, 2023
Ann Powell Judge
Evp, Chief Human Resources
xxxxxxxxxxxxx
$1101643

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2024
xxxxxxxxxxxxx
$27115
Mar 31, 2024
xxxxxxxxxxxxx
$189859
Mar 31, 2024
xxxxxxxxxxxxx
$253796
Mar 31, 2024
xxxxxxxxxxxxx
$291215

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
161,355,846Institution7.96%7,304,579,148
133,961,059Institution6.61%6,064,417,141
85,388,345Institution4.21%3,865,530,378
74,606,696Institution3.68%3,377,445,128
52,641,723Institution2.60%2,383,090,800
33,056,704Institution1.63%1,496,476,990
23,273,407Institution1.15%1,053,587,135
17,908,128Institution0.88%810,700,955
16,267,041Institution0.80%736,408,946
14,688,645Institution0.72%664,954,959

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
133,961,059Institution6.61%6,064,417,141
33,056,704Institution1.63%1,496,476,990
17,908,128Institution0.88%810,700,955
14,637,720Institution0.72%662,649,584
14,548,457Institution0.72%658,608,648
13,793,671Institution0.68%624,439,486
12,698,880Institution0.63%574,878,298
12,355,733Institution0.61%559,344,033
11,988,814Institution0.59%542,733,610
11,822,839Institution0.58%535,219,922

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
64,145,668Institution3.16%2,663,969,592
52,099,472Institution2.57%2,163,691,072
47,334,415Institution2.34%2,113,954,974
24,588,032Institution1.21%1,098,101,509
24,588,032Institution1.21%1,098,101,509
21,797,068Institution1.08%986,753,268
16,607,527Institution0.82%689,710,596
14,906,306Institution0.74%665,715,626
11,298,113Institution0.56%504,573,727
7,547,070Institution0.37%341,655,859

FAQ

Who Owns Bristol-Myers Squibb (BMY)?
According to the latest TipRanks data, approximately 26.25% of the company's stock is held by institutional investors, 0.34% is held by insiders, and 48.62% is held by retail investors.
    What percentage of Bristol-Myers Squibb (BMY) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 26.25% of Bristol-Myers Squibb (BMY) stock is held by institutional investors.
      What percentage of Bristol-Myers Squibb (BMY) stock is held by retail investors?
      According to the latest TipRanks data, approximately 48.62% of Bristol-Myers Squibb (BMY) stock is held by retail investors.
        Who owns the most shares of Bristol-Myers Squibb (BMY)?
        Vanguard owns the most shares of Bristol-Myers Squibb (BMY).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis